EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients

Rui Zhang, Danielle C. Spengler, Marie-Helene Saint-Hilaire, Anna D. Hohler

Advances in Parkinson's Disease · 2012

DOI: 10.4236/apd.2012.11002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Parkinson's Disease, 2012. Verfasst von Rui Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, R., Spengler, D. C., Saint-Hilaire, M., & Hohler, A. D. (2012). Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients. Advances in Parkinson's Disease. https://doi.org/10.4236/apd.2012.11002

Vancouver

Zhang R, Spengler DC, Saint-Hilaire M, Hohler AD. Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients. Advances in Parkinson's Disease. 2012. doi:10.4236/apd.2012.11002

BibTeX
@article{Zhang2012,
  author = {Zhang, Rui and Spengler, Danielle C. and Saint-Hilaire, Marie-Helene and Hohler, Anna D.},
  title = {Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients},
  journal = {Advances in Parkinson's Disease},
  year = {2012},
  doi = {10.4236/apd.2012.11002}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche